Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Y15 |
Synonyms | |
Therapy Description |
Y15 is a small molecule inhibitor of FAK, which inhibits cellular adhesion and colony formation, and decreases FAK autophosphorylation, potentially leading to reduced tumor growth (PMID: 31160603, PMID: 19571674). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Y15 | 1,2,4,5-benzenetetraamine tetrahydrochloride|FAK inhibitor 14 | FAK inhibitor 15 | Y15 is a small molecule inhibitor of FAK, which inhibits cellular adhesion and colony formation, and decreases FAK autophosphorylation, potentially leading to reduced tumor growth (PMID: 31160603, PMID: 19571674). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|